Concerns Over PREVAIL Act Persist, Even With Amendment To Shield Off-Patent Drugs
The Bill Received A Close Vote Of 11-10 By The Senate Judiciary Committee
Despite the US legislation gaining support from Democratic candidates, who have fought against anticompetitive pharma behavior, many have shared concerns that the amended PREVAIL Act will still negatively impact generic drugs.
